T 1212/01 (Pyrazolopyrimidinones for the treatment of impotence/PFIZER LIMITED ET AL) of 03.02.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T121201.20050203
- Date of decision
- 3 February 2005
- Case number
- T 1212/01
- Petition for review of
- -
- Application number
- 94916236.6
- IPC class
- A61K 31/505
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pyrazolopyrimidinones for the treatment of impotence
- Applicant name
- Pfizer Limited, et al
- Opponent name
- VIVUS INC.
ICOS Corp.
SCHERING-PLOUGH CORPORATION
Merck Patent GmbH
Eli Lilly and Company
Ortho-McNeil Pharmaceutical, Inc.
MOCHIDA PHARMACEUTICAL CO. LTD.
Sanofi-Aventis
Bayer AG, Leverkusen Konzernverwaltung RP Patente Konzern
EISAI Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd.
Tanabe Seiyaku Co., Ltd.
Bristol-Myers Squibb Company - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 56 1973
- Keywords
- Main and auxiliary requests 1 and 2 - added matter - yes
Auxiliary requests 3 to 5 - inventive step - no
Neither technical prejudice nor commercial success establishes inventive step - Catchword
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.